This site is intended for healthcare professionals only
LoginRegister
Delhi HC Seeks Response from UPSC on Plea for Reservation of Seats for Blind Candidates in Medical Services ExamSun's RACIRAFT Vs JB Pharma's RANRAFT: Delhi HC gives interim trademark protection to Sun Pharma
Dr Reddys Labs API Mirfield facility gets 7 USFDA observationsDr Reddy's Labs Switzerland incorporates wholly-owned subsidiary in Denmark
Regulatory Action Ahead for Entod Pharma: CDSCO directs Gujarat FDCA to act on PresVu claimsRegulatory Action Ahead for Entod Pharma: CDSCO directs Gujarat FDCA to act on PresVu claims
Sun Pharma, Alembic and 1 other recall productsMedtronic voluntary recalls MiniMed 600 series or 700 series insulin pumps due to potential risks of...
Natco Pharma partner Mylan settles patent litigation with Novo Nordisk over generic Ozempic in USNatco Pharma partner Mylan settles patent litigation with Novo Nordisk over generic Ozempic in US
USFDA issues 4 observations for Zydus Jarod injectable manufacturing plantLupin gets 5 USFDA observations for Pune biotech facility
Sun Pharma Gets CDSCO Panel Nod for Phase IV Trial of Esomeprazole Dual Release Tablets 80 mgSun Pharmaceutical Industry gets CDSCO Panel nod to study Aflibercept Injection
Record sales of Rs 200 crore achieved by Jan Aushadhi Kendras in SeptemberRecord sales of Rs 200 crore achieved by Jan Aushadhi Kendras in September
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalJnJ seeks USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple...
Shilpa Medicare arm partners with Orion Corporation for Recombinant Human Albumin for European MarketShilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin
Drug Safety Alert: IPC Flags Adverse Reactions linked to Tranexamic acid and MetoclopramideDrug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Tetracycline
AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITCAstrazeneca Calquence granted priority review by USFDA for previously untreated mantle cell lymphoma
X